WCN26-3459 COMPARATIVE CARDIOVASCULAR EFFECTIVENESS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS VERSUS DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN DIALYSIS PATIENTS WITH TYPE 2 DIABETES MELLITUS: A TARGET TRIAL EMULATION

Read full text Summarise with VIRAT
Authors: Hiroki Shimada, Toshiki Fukasawa, Kayoko Mizuno, Yuki Okazawa, Kasumi Yokogawa, Koji Kawakami
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been shown in several randomized trials to improve cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, evidence regarding their effectiveness in patients with end-stage kidney disease, particularly those receiving maintenance dialysis, remains limited. We aimed to compare the cardiovascular effectiveness of GLP-1RAs versus dipeptidyl peptidase-4 inhibitors (DPP-4is) among patients with T2DM undergoing maintenance dialysis.

Fields of Study & Subjects

Diabetes Treatment and Management Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104604–104604
Publication date
25 March 2026
Language
EN